Most cited papers in Synthesis of β-Lactam Compounds
What are the most cited papers in Synthesis of β-Lactam Compounds?
The most cited paper in Synthesis of β-Lactam Compounds is "Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals" (Edon Vitaku, David T. Smith, Jón T. Njardarson, 2014), with 6,486 citations. Next come "Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design" (2,856) and "“On Water”: Unique Reactivity of Organic Compounds in Aqueous Suspension" (1,686).
Showing 50 of 100 papers. Every paper with more than 247 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals Edon Vitaku, David T. Smith, Jón T. Njardarson · Journal of Medicinal Chemistry | 25 Sep 2014 | 6,486 |
| 2 | Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design Nicholas A. Meanwell · Journal of Medicinal Chemistry | 17 Mar 2011 | 2,856 |
| 3 | “On Water”: Unique Reactivity of Organic Compounds in Aqueous Suspension Sridhar Narayan, John Muldoon, M. G. Finn et al. · Angewandte Chemie International Edition | 21 Apr 2005 | 1,686 |
| 4 | Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets J. Bryan Smith, Anthony L. Willis · Nature New Biology | Jun 1971 | 1,528 |
| 5 | Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets Mats Hámberg, Bengt O. Samuelsson · Proceedings of the National Academy of Sciences | Sep 1974 | 1,420 |
| 6 | Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes Cláudio Viegas, Eliezer J. Barreiro, Carlos Alberto Manssour Fraga · Current Medicinal Chemistry | 30 Jun 2007 | 1,310 |
| 7 | Prescribed drugs containing nitrogen heterocycles: an overview Majid M. Heravi, Vahideh Zadsirjan · RSC Advances | 2020 | 1,190 |
| 8 | COX-2 inhibitors Christopher John Hawkey · The Lancet | 1999 | 1,182 |
| 9 | Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Brian G. Spratt · Proceedings of the National Academy of Sciences | Aug 1975 | 986 |
| 10 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Stuart A. Scott, Katrin Sangkuhl, Catherine M. Stein et al. · Clinical Pharmacology & Therapeutics | 22 May 2013 | 977 |
| 11 | Construction of Enantiopure Pyrrolidine Ring System via Asymmetric [3+2]-Cycloaddition of Azomethine Ylides Ganesh D. Pandey, Prabal Banerjee, Smita R. Gadre · Chemical Reviews | 25 Oct 2006 | 955 |
| 12 | Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects Paola Patrignani, Paola Filabozzi, Carlo Patrono · Journal of Clinical Investigation | Jun 1982 | 947 |
| 13 | How many antibiotics are produced by the genus Streptomyces ? Milind Watve, Rashmi Tickoo, Maithili M. Jog et al. · Archives of Microbiology | Nov 2001 | 934 |
| 14 | Coxibs and Cardiovascular Disease Garret A. FitzGerald · New England Journal of Medicine | 6 Oct 2004 | 901 |
| 15 | Cellular Cholesterol Efflux Mediated by Cyclodextrins Elisabeth P.C. Kilsdonk, Patricia G. Yancey, Genevieve W. Stoudt et al. · Journal of Biological Chemistry | Jul 1995 | 890 |
| 16 | The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. G J Roth, Philip W. Majerus · Journal of Clinical Investigation | Sep 1975 | 864 |
| 17 | Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2 Yan Cheng, Sandra C. Austin, Bianca Rocca et al. · Science | 19 Apr 2002 | 794 |
| 18 | Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties Philip Needleman, Amiram Raz, Mark S. Minkes et al. · Proceedings of the National Academy of Sciences | Feb 1979 | 783 |
| 19 | Towards a better aspirin John Robert Vane · Nature | 1994 | 703 |
| 20 | The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological Role Mark Henry Richmond, RICHARD B. SYKES · Advances in microbial physiology/Advances in Microbial Physiology | 1973 | 693 |
| 21 | Arachidonate lipoxygenase in blood platelets Diederik H. Nugteren · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | Feb 1975 | 619 |
| 22 | Metabolism of Fluorine-Containing Drugs Bongkyu Park, Neil R. Kitteringham, Paul M. O’Neill · The Annual Review of Pharmacology and Toxicology | Apr 2001 | 611 |
| 23 | An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs Cliff K. S. Ong, Phillip Lirk, Chi-Wing Tan et al. · Clinical Medicine & Research | Mar 2007 | 594 |
| 24 | Novel Syntheses of Azetidines and Azetidinones Alberto Brandi, Stefano Cicchi, Franca Maria Cordero · Chemical Reviews | 10 Sep 2008 | 586 |
| 25 | Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment Colin D. Funk, Lena B. Funk, Matthew E Kennedy et al. · The FASEB Journal | Jun 1991 | 576 |
| 26 | An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals Marcus Baumann, Ian R. Baxendale, Steven V. Ley et al. · Beilstein Journal of Organic Chemistry | 18 Apr 2011 | 560 |
| 27 | Inhibition of platelet prostaglandin synthetase by oral aspirin. John W. Burch, Nancy Stanford, Philip W. Majerus · Journal of Clinical Investigation | Feb 1978 | 558 |
| 28 | β-Lactams: Versatile Building Blocks for the Stereoselective Synthesis of Non-β-Lactam Products Benito Alcaide, Pedro Almendros, Cristina Aragoncillo · Chemical Reviews | 25 Jul 2007 | 532 |
| 29 | Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution Natalie C. J. Strynadka, Hiroyuki Adachi, Susan E. Jensen et al. · Nature | Oct 1992 | 529 |
| 30 | Effects of Intravenous Patient-Controlled Analgesia with Morphine, Continuous Epidural Analgesia, and Continuous Three-in-One Block on Postoperative Pain and Knee Rehabilitation After Unilateral Total Knee Arthroplasty François J.E. Singelyn, M. Deyaert, Daniel Joris et al. · Anesthesia & Analgesia | Jul 1998 | 526 |
| 31 | Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health Asad Ullah Khan, Lubna Maryam, Raffaele Zarrilli · BMC Microbiology | 27 Apr 2017 | 518 |
| 32 | Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity William D. Kingsbury, Jeffrey C. Boehm, Dalia R. Jakas et al. · Journal of Medicinal Chemistry | 1991 | 518 |
| 33 | The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase Patrick J. Loll, Daniel Picot, R. Michael Garavito · Nature Structural Biology | Aug 1995 | 490 |
| 34 | Asymmetric Catalysis with “Planar-Chiral” Derivatives of 4-(Dimethylamino)pyridine Gregory C. Fu · Accounts of Chemical Research | 5 May 2004 | 476 |
| 35 | Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes F.G.M. Snijdewint, Paweł Kaliński, E A Wierenga et al. · The Journal of Immunology | Jun 1993 | 476 |
| 36 | The asymmetric synthesis of aziridines Helen M. I. Osborn, Joseph B Sweeney · Tetrahedron Asymmetry | Jun 1997 | 467 |
| 37 | Regioselectivity in the ring opening of non-activated aziridines Sonja Stanković, Matthias D’hooghe, Şaron Çatak et al. · Chemical Society Reviews | 6 Sep 2011 | 465 |
| 38 | Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2 Denis Riendeau et al. · Journal of Pharmacology and Experimental Therapeutics | Feb 2001 | 461 |
| 39 | Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients Babette Barbash Weksler, Stuart B. Pett, Daniel Rivera Alonso et al. · New England Journal of Medicine | 7 Apr 1983 | 450 |
| 40 | Biologically active γ-lactams: synthesis and natural sources Joséphine Caruano, Giulio G. Muccioli, Raphaël Robiette · Organic & Biomolecular Chemistry | 2016 | 434 |
| 41 | Studies on organophosphorus compounds XX. syntheses of thioketones B. S. Pedersen, Sten Scheibye, Nils H. Nilsson et al. · Bulletin des Sociétés Chimiques Belges | 1978 | 432 |
| 42 | The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor Petpiboon Prasit et al. · Bioorganic & Medicinal Chemistry Letters | Jul 1999 | 429 |
| 43 | The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets D. C. B. Mills, J. Bryan Smith · Biochemical Journal | 1971 | 425 |
| 44 | The Development of the First Catalyzed Reaction of Ketenes and Imines: Catalytic, Asymmetric Synthesis of β-Lactams Andrew E. Taggi, Ahmed M. Hafez, Harald Wack et al. · Journal of the American Chemical Society | 16 May 2002 | 419 |
| 45 | P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use Lars C. Wallentin · European Heart Journal | 24 Jul 2009 | 408 |
| 46 | CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization Arthur R. English, James A. Retsema, Arthur E. Girard et al. · Antimicrobial Agents and Chemotherapy | Sep 1978 | 403 |
| 47 | Naturally-occurring .BETA.-lactamase inhibitors with antibacterial activity. ALLAN G. BROWN, Douglas S. Butterworth, Martin Cole et al. · The Journal of Antibiotics | 1976 | 397 |
| 48 | International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies Dominick Joseph Angiolillo et al. · Circulation | 30 Oct 2017 | 396 |
| 49 | Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans Nagy A. Farid, Atsushi Kurihara, Steven A. Wrighton · The Journal of Clinical Pharmacology | Dec 2009 | 395 |
| 50 | Prostaglandin Synthetase Inhibitors T. Y. Shen | 1977 | 392 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.